Arkolith/Stocks/60 DEGREES PHARMACEUTICALS, INC.

60 DEGREES PHARMACEUTICALS, INC.

◍ Confluence graph
Tracked 13F Holders
0
13F Value (tracked)
$0
Insider Net · 180d
$10K
1↑ 0↓
Recent Filings
15
Smart-money sentimentBullish
BearishBullish
13F funds (latest Q)0 adding · 0 trimming
Insider net (180d)+$10K
Price-derived chart withheld or not yet available for 60 DEGREES PHARMACEUTICALS, INC..
Build

Use 60 DEGREES PHARMACEUTICALS, INC. data in an agent

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp
Build

Ask your agent who owns 60 DEGREES PHARMACEUTICALS, INC.

This stock page is the Follow view. The Build view lets your agent query 60 DEGREES PHARMACEUTICALS, INC. owners, fund changes, insider filings, and source links through REST or MCP.

Get a key Compare plans13F data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/stocks/SXTP"
Ask your agent
Use Arkolith to show who owns 60 DEGREES PHARMACEUTICALS, INC.,
which funds added or reduced it, and which
SEC filings prove each claim.

Top institutional holders

0 tracked 13F filers

Not held in any tracked 13F filing yet.

Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

Insider activity (Form 4)

Full insider page →
Buys · 180d
$10K
1 insiders
Sells · 180d
$0
0 insiders
Net
$10K
1 P/S txns
Signal
Net Buying
open-market
DateInsiderRoleActionSharesValue
Jun 12, 2026DOW GEOFFREY SPresident and CEO, DirectorBuy (P)7K$10K
Dec 15, 2025DOW GEOFFREY SPresident and CEO, DirectorBuy (P)10K$8K
Dec 11, 2025DOW GEOFFREY SPresident and CEO, DirectorBuy (P)4K$3K
Dec 10, 2025DOW GEOFFREY SPresident and CEO, DirectorBuy (P)9K$9K
Sep 12, 2025DOW GEOFFREY SPresident and CEO, DirectorGrant (A)7K$10K
Jun 9, 2025DOW GEOFFREY SPresident and CEO, DirectorGrant (A)4K$13K
Jun 3, 2025XU CHERYLDirectorBuy (P)2K$6K
Jun 3, 2025XU CHERYLDirectorBuy (P)3K$9K
Jan 17, 2025Landon KristenChief Operating OfficerGrant (A)5K$0
Jan 17, 2025MILLER TYRONECFOGrant (A)12K$0
Jan 17, 2025DOW GEOFFREY SPresident and CEO, DirectorGrant (A)14K$0
Jan 2, 2025MILLER TYRONECFOGrant (A)75K$0

Recent filings

15 shown

Browse more

All tracked stocks A–Z60 DEGREES PHARMACEUTICALS, INC. insider filings13F funds A–Z

13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for SXTP. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes. Every panel above is one call to the Arkolith API & MCP server.